Search images on Google Product Monograph
Active Ingredients:
DIN: 02248296
Dosage Form(s): SOLUTION
Route(s) of Administration: INTRAVENOUS
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- M05 - DRUGS FOR TREATMENT OF BONE DISEASES (ATC, WHO, Wiki)
- M05B - DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, WHO)
- M05BA - Bisphosphonates (ATC, WHO)
- M05BA08 - ZOLEDRONIC ACID (WHO)
Reference brand drug: Aclasta
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 5ML
External Links for Zometa Concentrate:
Search on Google
- Zometa Concentrate side effects
- Zometa Concentrate dosage
- zoledronic acid side effects
- zoledronic acid dosage
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find zometa concentrate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.